Matt Drew, Vice President, Sales and Marketing

Frederick, MD


Virtual Presentation

At RoosterBio, we are pioneers in radically simplifying the use of adult human mesenchymal stem/stromal cells to propel the commercialization of regenerative technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry-leading supporting quality documentation, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to a rapid acceleration in products coming to market that incorporate these technologies. RoosterBio is driving the transition of MSCs from a scarce resource into an abundant resource where billions are the new millions. By increasing their availability and decreasing the complexity required to incorporate them into products, we are ushering in a new era of productivity and standardization in regenerative medicine. Our innovative translation-friendly products are high volume, affordable, and well-characterized hMSCs paired with highly engineered media systems that ease the regulatory pathway and accelerate speed to market.

By using this website you agree to accept our Privacy Policy and Terms & Conditions